Atlas Trials

EGFR-TKI Resistant Mutation

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch EGFR-TKI Resistant Mutation

RecordFirmDate
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations (NCT05256290)Black Diamond Therapeutics, Inc.2022-03-31
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) (NCT05598528)Second Xiangya Hospital of Central South University2021-09-28
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M (NCT02972333)Shandong Cancer Hospital and Institute2016-12-01
Human EGFR Mutations Quantitative Detection Kit (Real-time Fluorescent PCR Method) (NCT02661009)GenoSaber2016-01-01
Weekly Use First-generation EGFR-TKI in the Treatment of EGFR-TKI Acquired Resistance Non-small Cell Lung Cancer (NSCLC) (NCT02575560)Qingdao Central Hospital2015-10-01
A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment (NCT01994057)Sun Yat-sen University2012-09-01

Track EGFR-TKI Resistant Mutation automatically

Every clearance here is in the API, with alerts when new ones post.